Point72 Asset Management L.P. Purchases Shares of 765,922 Tilray Inc (NASDAQ:TLRY)

Point72 Asset Management L.P. purchased a new stake in shares of Tilray Inc (NASDAQ:TLRY) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 765,922 shares of the company’s stock, valued at approximately $1,348,000. Point72 Asset Management L.P. owned 0.08% of Tilray as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in TLRY. Ferguson Wellman Capital Management Inc. bought a new stake in shares of Tilray during the 3rd quarter valued at about $26,000. Signature Estate & Investment Advisors LLC bought a new stake in shares of Tilray during the 2nd quarter valued at about $29,000. Jeppson Wealth Management LLC purchased a new position in shares of Tilray during the 2nd quarter valued at about $33,000. Vanguard Capital Wealth Advisors purchased a new position in shares of Tilray during the 2nd quarter valued at about $34,000. Finally, Pallas Capital Advisors LLC purchased a new position in shares of Tilray during the 2nd quarter valued at about $37,000. 9.35% of the stock is currently owned by institutional investors.

Tilray Stock Down 2.3 %

TLRY stock opened at $1.28 on Wednesday. Tilray Inc has a twelve month low of $1.25 and a twelve month high of $2.97. The company has a quick ratio of 1.57, a current ratio of 2.47 and a debt-to-equity ratio of 0.08. The stock has a market cap of $1.16 billion, a P/E ratio of -4.74 and a beta of 2.09. The business’s 50-day moving average price is $1.51 and its 200-day moving average price is $1.69.

Tilray (NASDAQ:TLRY) last posted its quarterly earnings results on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, hitting analysts’ consensus estimates of ($0.04). Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The company had revenue of $200.00 million for the quarter, compared to analysts’ expectations of $218.70 million. During the same period in the previous year, the firm earned ($0.10) EPS. The firm’s revenue was up 13.0% compared to the same quarter last year. On average, equities research analysts forecast that Tilray Inc will post -0.14 EPS for the current year.

Insider Buying and Selling

In other Tilray news, CFO Carl A. Merton purchased 26,000 shares of the stock in a transaction that occurred on Friday, November 15th. The shares were bought at an average cost of $1.36 per share, with a total value of $35,360.00. Following the acquisition, the chief financial officer now owns 26,000 shares in the company, valued at approximately $35,360. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.87% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Separately, Roth Mkm lowered their price objective on Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a research report on Friday, October 11th.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.